Zhixin Finance APP news, Hualan Vaccine (301207.SZ) released the semi-annual report for 2024, with a revenue of 35.529 million yuan during the reporting period, a decrease of 76.25% year-on-year; net income attributable to shareholders of the listed company decreased by 76.65% to 25.2744 million yuan; net loss attributable to shareholders of the listed company after deducting non-recurring gains and losses was 21.3215 million yuan; and the basic earnings per share was 0.0421 yuan/share.